INTRODUCTION
Considered as the most dreaded transmittable infection with no known cogent medical cure, the human immunodeficiency virus (HIV), which often transmute to terminal irreversible manifestation -the acquired immunodeficiency syndrome (AIDS) have posed a challenging treat to the scientific world. The amiable quest of tackling this life threatening disease -HIV/AIDS infection has been through the application of mathematical modeling, which allows the utilization of significant knowledge of numerical methods for the optimization of host target immune system cells and the minimization of systemic cost, while suppressing viral victors below detectable clinical assay, see for examples the studies of models [1] [2] [3] [4] .
Furthermore, following the emerging new cases of multiplicity of HIV and its allies of pathogenic infections, it has become more unsafe and agreeably incomplete to mathematically and biological model eradication of HIV/AIDS infections without accounting for the epidemiological and biological behavior of the consequences of allying pathogenic infections. The seeming varying positive contributions from numerical methods in the dynamics of single strain HIV infection have considerably been extended to the diagnosis of the epidemiological and biological behaviors of dual HIV-pathogen infectivity as has been exemplified by models [5] [6] [7] [8] [9] . Consequentially, the varying results from these later models have been of immense importance in subduing the tenacity of the surging cases of dual viral infectivity.
Application of quantum locally optimal algorithm of successive approximation as a concept of numerical methods, which accounted for the mathematical simulations of human immune systems problems using varying optimization control strategies for immune processes and HI-virus infections were adequately discussed in the models [2, [10] [11] [12] [13] [14] [15] . Of particular interest to this present paper, is the mathematical formulation by [16] , which was based on the findings of model [11] . The model studied the numerical methods of optimal control of HIV-infection dynamics using quantum locally optimal algorithm of successive approximation technique. That model considered 7 -differential equations framed around 7 -subgroups of the populations. The study investigated the role of numerical methods in solving complex problems in medicine and was able to define the lifespan of infected patients in terms of continuous and intermittent application of therapy. The methodological key components of the model involves the . However, the above model lacks the finite biological attributive roles of delay intracellular and cell-mediated immune effectors response. Furthermore, the outcome of the result does not spelt the effects of allies of HIV infectivity.
Articulating the above seeming silent but unavoidable epidemiological constraints and motivated by the studies [1, 5] , the present paper proposes and formulates using ordinary differential equations, an improved complex nonlinear 10-Dimensional dual HIV-pathogen dynamic delay-differential model, prime with the task of not only overcoming the lapses of model [16] but also to account for the methodological application of multiple chemotherapy treatment (MCT) in dual delay HIV-pathogen infections incorporated with delay intracellular and immune effectors response. Therefore, the present model is studied under the auspices of 10-subpopulations, which includes the critical roles of immune effectors response and two treatment functions 1 () t  and 2 () t 
. The methodology involves dual HIVpathogen infections on target cells distorted with reverse transcriptase inhibitors (RTI) and protease inhibitors (PIs) as treatment factors and clinically sandwich in two treatment discontinuation chambers denoted by
with which the index -infection delay intracellular is accommodated. The variations of the present model with those of [5] [6] [7] [8] [9] are the incorporation of well-defined treatment functions 1 () t  and 2 () t  (on RTI and PIs). Moreso, the present model clearly articulates the mathematical representation of the biological attributes of the model state variables (to be defined in section 2).
Furthermore, to appreciate the critical functions of delay intracellular immune andeffectors response, we leap on the innovative ideas of the mathematical formulations studied by [1, 5] . Thus, in the quantitative analysis of our complex nonlinear model to be presented as on optimal control problemand applying from the vast branches of numerical methods, we explore Hamilton-Pontryagin' function to establish the model quantum locally optimal algorithm for successive approximations. The approach of which had earlier been initiated in the vector of phase variables of [16] .
The entire model is explicitly constituted into 6 sections with section 1 devoted to the introductory aspect. The material and methods adopted for this investigation, which involves the mathematical novelty of the study presented as problem statement model and transformed to an optimal control problem are develop in section 2. The analysis of the derived model is treated in section 3. Here, the model explores classical optimization technique known as Hamilton-Pontryagin's function in the evaluation of the system quantum locally optimal algorithm of successive approximations. Numerical simulations using in-built Runge-Kutter of order of precision 4 in a Mathcad surface and results of investigations are contained in section 4. Section 5 discusses the implications of the applied model and analyzes the obtained results of section 4. Finally, we draw in section 6, succinct conclusion and recommendations on the basis of achieved result. It is therefore anticipated that this present study will to a greater extent address the curiosity to overcome the curative impediment of dual HIV-pathogen infections.
MATERIAL AND METHODS
Here, we shall accomplish the intents of this section with crystal focus on presentation of mathematical problem statement of the model and the transformation of the derive model to an optimal control problem.
Mathematical Problem Statement for Uncontrolled Treatment
As a led way, we shall as highlighted in section 1; formulate the mathematical problem statement from the viewpoints of model [1, 5, 8, 16] . From model [16] , the study was formulated as a 7 -Dimensional vector of phase variables. The epidemiological derivation of the model was given as: 
The epidemiological and biological descriptions of these state variables and parameters of model (1) will be reason out from the definition of our derived model (2) below. This becomes obvious in order to avoid the unnecessary repetition of definitions of some rerated biological parameters (functions).
Suppose the key components of the state variables for the present study are define as: (1) and invoking the innovative idea from [1] in relation to delay intracellular; the articulated critical role of cell-mediated immune effectors response as investigated by [5] in conjunction with the versatile knowledge of dual HIV-pathogen infectivity of model [8] , we thus arrive at a modified and reformulated epidemiological and biological model governed by 2 11 ()
( ) 
P t P t P t . So that if we let
i Q presents the model state variables, then
Thus, equations of model (2) constitute the basic model with which we conduct the current present study. Unlike model (1), the innovative aspect of model (2) is reveal by the incorporation of sixth, seventh and eighth equations, which also have its biological contributive effects on other equations of the model. The epidemiological definitions of equations of model (2) and their mechanism of interactions can thus be given as follows: from the first equation, the term
is the source/proliferation of uninfected T-cells,
is the replication intensity of T-cells due to dual infections. This term plays crucial role in the immune system functioning by reacting to foreign matters (virions) ingress. Thus generating and increasing the concentration of immune effectors response. The last term of this equation
is the rate at which T-cells becomes infected and are cleared by treatment function 1 () t  .
From the second equation, since treatment does not affect resistive infected cells and resistive virions, the first term is the product of the exponential rate reflecting the death rate and time delay, which affects the inflow of infected T-cells by dual infectivity. The infected T-cells are cleared at the rate 2 ()
the dual viral infections sustain its presence by the term
is the loss rate of infected cells due to defense mechanism of immune effectors response.
In the third equation, the first term [( ( 
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Page 5 The fourth and sixth equations having related terms represents the activities of the sensitive viral load and parasitoid-pathogen in the T-cells. Furthermore, it is biologically obvious that when virions concentration in the blood plasma is large enough, defense mechanism transmutes information to the T-lymphocytes following chemotherapy application. Thus, sensitive virions are transmuted to resistive virions. This interactive process in model (2) is defined by the inclusion of the discontinuation function n G , which is mathematically expressed as:
where, r G is the discontinuation chambers of resistant virions replaced by sensitive virions following the administration of chemotherapy.
Drawing from model [11] , where model [16] generated is basis, the treatment functions 1 () t  and 2 () t  are defined as function of time for single infection HI-virus. For model [11] , which accounted for uncontrolled treatment i.e. the first five equations of model (1), the time function 1 () t  and 2 () t  were governed by 1 1 0
The model [16] (1) clearly define the treatment function of model [16] , which is derived as: For dual HIV-pathogen virions as in the case of the present study, having parameter values as inscribed in table 2, the treatment functions is adequately describe by ninth and tenth equations of model (2) . Therefore, from equations (4) and (5), the first functions defines the decreasing rate of T-cells infected by sensitive virions, while the second functions describe the effect of suppressed virions inflow in the blood plasma from lymphoid system. We must note that the resistive virions components are not affected by chemotherapy treatments.
Remarkably, the functions 1 () t  and 2 () t  defines the dynamic characters of treatment interactions processes, which accounts for intermittent treatment schedules in our present model. Epidemiologically, it becomes accommodating to introduce as in model (2) Thus, in concretizing the validity of model (2); comparative test for equations (4) and (5) as well as the optimality system (to be determined in the later section), we establish a set of clinically compactible data for the state variables and parameters values as summarized in tables 1 and 2 below: 
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Page 8 According, the appreciation of the significance and slight variations (if any) of the treatment functions for the present study and those of models [11, 16] will be illustrated in section 4.
Statement of Optimal Control for MCT
The introduction of optimization control strategy to treatment of infectious diseases (i.e. HIV and it allied pathogenic infections) is primarily hinge on the objective of prolongation of lifespan of infected patients following the application of prescribed chemotherapy. The measure by which the resulting outcome of an optimal control is accessed particularly for HIV infection is the quantitative level of healthy CD4 + T cell count concentration and the production of adaptive natural anti-HIV immune cytotoxic T-lymphocytes (CTLs) in relation to reduction in cost of treatment.
Therefore, in formulating the mathematical problem, which allows the investigation of the quantitative characteristics of these healthy T-cells and that of immune effectors response, the objective functional must be quantitatively formulated. For a study of model (2), having 10-Dimensional vectors phase space, the mathematical objective is considered in terms of its trajectories in a hypersurface bounds. From the study [18] , the lowest severity category of T-cells concentration that leads to the development of AIDS ending with a lethal outcome is when viremia level is 200 T cells unit per .
cu mm .
So that if we let this low level viremia bound be T  , then the optimal problem of prolongation of patients lifespanis achievable if we set the bound on immune system to obtain
This is to say that the objective functional Q , that define the optimization treatment problem is derive as:
[ ( ), ( )] { / ( ) } hu Q r t r t t t T t T
for which the trajectory of model (2) attain hypersurface (6) at initial treatment of infection set-point. The value of h t in equation (7), is determined by the choice of treatment control functions 1 ()
Hence, the numerical algorithm is geared towards establishing the functions for which equation (7) Thus, equation (7) can be rewritten as:
Q r t r t t t T t T
Then we are to analyze the objective functional (8) to establish the quantum locally optimal algorithm of successive approximation in our next section.
QUANTUM LOCALLY OPTIMAL ALGORITHM FOR DUAL HIV-PATHOGEN INFECTIVITY
In this section, we shall derive the phase coordinates of model (2) using the control technique of optimization control method to establish the equation for successive increment functional and the quantum algorithm of control.
Phase Coordinates for the System Model
Using the phase conjugate, we shall explore the optimization method initiated by [19] to transform the 10-Dimensional state variables to phase coordinates typical of model (2) 
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Next, we derive the corresponding system of delay-differential equations for the costate variables i.e. 
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Equation for Successive Increment Functional
For a specific optimal control problem, one approach of resolving the problem of healthy CD4 + Tlymphocytes maximization is the process of successive increment of control functional constructed as follows: Let the control functions be 11 () r r t  and 22 () r r t  , then we can solve the Cauchy problem for model (2) having initial conditions as specified in model (2) . Then, the trajectory of the control functional is obtained as: 
T t T t T t V t V t P t P t M t t t t t t
is determined in conjunction with the values of functional (7) on the supersurface (6) . Therefore, we present the functional (7) (17) and (7) is thus:
Q Q r t r t r t r t Q r t r t
which is computed using equations (11)- (15) (10) and its trajectory corresponding to the right-hand side of equation (11) such that we integrate using boundary conditions (12) and accounting for equations (14) and (15) 
t f t f t f t f t f t f t f t f t f t
In this considered problem, the change in functional (12) , which is determined with the aid of equations (16) and (19) , is obtained as follows: Of note, is the fact that for a nonlinear delay-differential equation as model (2) , the method of successive increment of control measure is achieved provided the following two conditions are satisfied: i) -the trajectory iteration is superimposed by any external source, ii) -the change in the control measure values are sufficiently small. The proof is standard and could be found in [4, 9] .
Quantum Locally Optimal Algorithm
A satisfactory application of equation (20) in simulation of successive increment control requires the clinical conduct of both the choice of magnitude of the change controls and the rational localization of these changes. Condition (ii) above is provided by the localized small time interval i.e. (21), the resulting control quanta become: Next, we present the simulation of the costate variables as seen in fig. 4 (a-c) below: fig. 4(a-c) , which shows the reverse in the increase (or decrease) as is the treated case (in fig. 3(a-c) ), signifies the existence of the overall outcome of the investigation.
DISCUSSION
In the literature of this present study, we had used ordinary differential equations to seek for the determination of optimal treatment strategies for a complex nonlinear 10-Dimensional dynamic dual HIVpathogen delay-differential model. The intents of the model were to overcome the constraints of defining the critical roles of delay intracellular and immune effectors response for dual delay HIV-pathogen infections. Moreso, we formulated the model to account for the methodological application of multiple chemotherapies on incorporated dual delay HIV-pathogen infections.
Importantly, under allowable dual treatment discontinuation chambers, which suggested successive approximation processes with step-wise variations of predominant parameters till desired convergence are achieved, the model was presented as an optimal control problem with terminal time objective functional. The method of analysis explored was classical Hamilton-Pontryagin function for the evaluation of the derived system quantum locally optimal algorithm.
For simplicity and significant comparative analysis, numerical simulations for both untreated and treated cases were demonstrated along with the outcome of the co-state variables. Furthermore, the essence of enhanced treatment functions were simulated in comparison to those related prior studies of models [11, 16] . Results of numerical simulations showed that treatment functions for model [11] , where control variable was not introduced resulted to very large utilization in the amount of RTI and PIs required in the duration of investigation. With the introduction of control variables as was the case in [16] , lesser amount of treatment functions (RTI and PIs) was required. The present model in addition to state components of model [16] , further incorporated delay intracellular and immune effectors response, which completely saw to a more reduced amount of treatment functions for the entire investigation duration -see fig. 1(a-c) .
The consequences of uncontrolled treatment function were evaluated in fig 2(a-c) . The solution of which could not guarantee the attainment of global maximum of optimized functional. The local maximum attained here, was the direct consequence of the only natural anti-HIV-pathogen, the immune effectors response.
Agreeably, the introduction of control variables as simulated by fig. 3(a-c) and affirmed by fig. 4 (a-c) illustrated successive approximations of control quanta by ways of choice variations of predominant parameters. This result validated the convergence control quanta of equation (22). Of note, the inclinative parabolic trajectory of the hypersurface of () u Tt was a clear indication of the embedded novelty of the study when compared with those of models [8, 11, 16] .
Furthermore, the optimal drug treatment protocol led to desired maximal healthy CD4 + T cells, immune effectors and suppressed infectious viral load and pathogen. The late decline in CD4 + T cells suggested possible drug resistance and high presence of resistive infectious cells and virions. Finally, the never eliminated immune effectors response is arguably a function of the toxicity of the presence of dual virions infectivity. Suggestively, we note that this present quantum locally optimal algorithm for successive approximation for maximal concentration of healthy T-lymphocytes is not necessarily the only or most efficient technique but was inevitably sufficient to produce an accurate solution in an acceptable amount of drug validity period for dual delay HIV-pathogen infections.
CONCLUSION
We present a necessary and sufficient quantum locally optimal algorithm for successive approximation technique, which produced an accurate solution in an acceptable amount of drug validity period for the treatment of dual delay HIV-pathogen infections. The model was formulated as an optimal control problem structured on a nonlinear complex 10-Dimensonal mathematical differential model with terminal time objective functional. The result of numerical simulations not only affirmed the maximization of healthy T-lymphocytes and maximal sustained cytotoxic T-lymphocytes as a function of high intensity of successive iterations of multiple chemotherapy, which were more rewarding at onset of infection but is sufficiently attributed to the immense critical role of incorporated delay intracellular and boosted natural adaptive immune effectors response. Furthermore, the enhanced significant reduction in systemic cost was a function of delay intracellular, which accounted for intermittent chemotherapy discontinuation. Decline in healthy CD4 + T cells suggests systemic discontinuation or change in chemotherapy administration. Therefore, the study advocates for a more articulated mathematical model and medical innovations that could address the persistent resistive infectious components, which were a thwarting factors.
